Über diesen Podcast
<p>On The Pen is the leading GLP-1 news podcast and platform covering obesity medicine, FDA actions, drug shortages, access policy, and the business of NuSH therapies. The podcast is in the top 0.5% of all podcasts globally, and On The Pen is a top Substack best-seller.</p><p><br /></p>
211 Folgen · Medizin
On The Pen GLP-1 News
Über diesen Podcast
<p>On The Pen is the leading GLP-1 news podcast and platform covering obesity medicine, FDA actions, drug shortages, access policy, and the business of NuSH therapies. The podcast is in the top 0.5% of all podcasts globally, and On The Pen is a top Substack best-seller.</p><p><br /></p>
Neue Folgen
- Ozempic & Zepbound Are Changing America in Ways Nobody Expected7. Okt. · 25 Min.
- They TRIPLED Wegovy Dose, Does it Beat Zepbound?1. Okt. · 31 Min.
- Retatrutide in Court, Compound GLP-1 Under Fire22. Sept. · 30 Min.
- 17% Weight Loss in 16 Weeks… Is This Better Than Retatrutide?15. Sept. · 30 Min.
- GLP-1 for 6 Year Olds? Here’s What the Trial Actually Found8. Sept. · 26 Min.
- We’re Solving Obesity. Now Who Pays for It?2. Sept. · 25 Min.
- GLP-1 Coverage Is COLLAPSING in 202726. Aug. · 35 Min.
- $50 Zepbound Incoming? China Has US in a GLP-1 “Chokehold”18. Aug. · 45 Min.
- 200 GLP-1 Deaths, Chrissy Metz & a Stunning Harvard Study12. Aug. · 31 Min.
- Eli Lilly Earnings Call Recap: Retatrutide News7. Aug. · 1 Std. 00 Min.
sharemy.show/de/on-the-pen-glp-1-news
Für ein Plakat oder eine Folie.